Dr Pierre Cordelier has been Director of the Toulouse Cancer Research Centre (CRCT) since 1 September 2023. Pierre Cordelier is Director of Research at INSERM and former President of the French Society of Cell and Gene Therapy (SFTCG). He heads the ImPACT research team at the CRCT and is renowned for his translational and transdisciplinary research into pancreatic cancer.

To ensure the success of his management project, Pierre Cordelier has surrounded himself with leading scientific figures who are experts in the fields of transfer research, transdisciplinarity and technology. Professor Elizabeth Cohen-Jonathan Moyal is head of the radiotherapy department at the Toulouse-Oncopole University Cancer Institute and of the RADOPT research team at the CRCT, and is deputy director in charge of clinical affairs. Dr Frédéric Lopez, Director of the CRCT’s Technology Unit, is in charge of technological issues. Sébastien Guibert, Administrative Secretary General, is responsible for the CRCT’s support services.

The mission of Pierre Cordelier and his management team is to strengthen links with the clinic, offer cutting-edge technologies and ensure efficient administrative management for translational oncology research, from discovery to clinical application, for all the CRCT’s teams.

Toulouse cancer research, grouped within a network whose legal framework is the Public Interest Group (GIP) Toulouse University Cancer Institute (IUCT), has set up a unique International Scientific Board (ISC) to help structure local research and care. The current ISC is composed of 13 French and foreign members, clinicians and researchers, but other personalities may be contacted to reinforce the SAB according to the new research fields to be assessed.

The SAB’s main missions are to:

• to advise on the scientific strategy to increase the visibility and attractiveness of the Toulouse site – to evaluate the medical-scientific activity of the research and care programs.
• to evaluate projects submitted in response to internal AAPs (those of the IUCT, IUCT-Oncopole and CRCT, and/or the Toulouse Cancer Santé Foundation) and applications from teams on the site.

More specifically, in the context of the CRCT, the ISC has a mission to analyse and advise on the CRCT’s strategy and scientific project, on its recruitment policy, and also on the Unit’s renewal project, prior to the evaluation of the teams by the national authorities.

The ISC, by playing its role at the same time on the CRCT, the Research College of the GIP IUCT and the Toulouse Cancer Santé Foundation, has a global vision which enables it to appreciate the priorities to be supported and the initiatives to be encouraged.